Dean A. Wacker

742 total citations
19 papers, 414 citations indexed

About

Dean A. Wacker is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dean A. Wacker has authored 19 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dean A. Wacker's work include Chemical Synthesis and Analysis (5 papers), Receptor Mechanisms and Signaling (4 papers) and Synthesis and Biological Evaluation (4 papers). Dean A. Wacker is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Receptor Mechanisms and Signaling (4 papers) and Synthesis and Biological Evaluation (4 papers). Dean A. Wacker collaborates with scholars based in United States, Germany and Sweden. Dean A. Wacker's co-authors include A. Richard Chamberlin, Jenny Bain, Keith J. Miller, Matthew H. Lyttle, Edward S. Diala, Thomas A. Dix, Charles Glabe, Jeffrey Varnes, Robert M. Knabb and Kan He and has published in prestigious journals such as Biochemistry, Journal of Neurochemistry and The Journal of Organic Chemistry.

In The Last Decade

Dean A. Wacker

18 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dean A. Wacker United States 12 248 150 60 49 37 19 414
Marie-Noëlle Dufour France 11 406 1.6× 247 1.6× 63 1.1× 29 0.6× 27 0.7× 16 586
Chongwu Zhang United States 8 310 1.3× 205 1.4× 64 1.1× 17 0.3× 37 1.0× 9 424
V. V. Suresh Babu India 14 274 1.1× 157 1.0× 35 0.6× 15 0.3× 31 0.8× 35 496
Tadashi Tatsumi Japan 10 213 0.9× 183 1.2× 18 0.3× 29 0.6× 32 0.9× 26 353
Don O. Somers United Kingdom 12 371 1.5× 412 2.7× 75 1.3× 57 1.2× 27 0.7× 17 782
Lars Linderoth Denmark 11 330 1.3× 84 0.6× 16 0.3× 28 0.6× 14 0.4× 14 457
Jeffrey Varnes United States 11 97 0.4× 122 0.8× 32 0.5× 46 0.9× 27 0.7× 20 260
Ronald Wolin United States 13 213 0.9× 279 1.9× 36 0.6× 39 0.8× 30 0.8× 23 503
Mark Munson United States 12 351 1.4× 204 1.4× 22 0.4× 66 1.3× 19 0.5× 20 482
J.‐R. DORMOY France 6 501 2.0× 382 2.5× 54 0.9× 49 1.0× 14 0.4× 11 647

Countries citing papers authored by Dean A. Wacker

Since Specialization
Citations

This map shows the geographic impact of Dean A. Wacker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean A. Wacker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean A. Wacker more than expected).

Fields of papers citing papers by Dean A. Wacker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean A. Wacker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean A. Wacker. The network helps show where Dean A. Wacker may publish in the future.

Co-authorship network of co-authors of Dean A. Wacker

This figure shows the co-authorship network connecting the top 25 collaborators of Dean A. Wacker. A scholar is included among the top collaborators of Dean A. Wacker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean A. Wacker. Dean A. Wacker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Carpenter, Joseph, Gang Wu, Ying Wang, et al.. (2021). Discovery of BMS-986318, a Potent Nonbile Acid FXR Agonist for the Treatment of Nonalcoholic Steatohepatitis. ACS Medicinal Chemistry Letters. 12(9). 1413–1420. 6 indexed citations
2.
Ye, Xiang‐Yang, Ying Wang, Karen A. Rossi, et al.. (2014). Synthesis and structure–activity relationship of dihydrobenzofuran derivatives as novel human GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 24(11). 2539–2545. 18 indexed citations
3.
Miller, Keith J. & Dean A. Wacker. (2010). Discovery and Development of 5-HT2CReceptor Agonists for Obesity: Is There Light at the End of the Tunnel?. Future Medicinal Chemistry. 2(12). 1761–1775. 3 indexed citations
4.
5.
Wacker, Dean A. & Keith J. Miller. (2008). Agonists of the serotonin 5-HT2C receptor: preclinical and clinical progression in multiple diseases.. PubMed. 11(4). 438–45. 30 indexed citations
6.
Varnes, Jeffrey, Dean A. Wacker, Donald Pinto, et al.. (2007). Structure–activity relationship and pharmacokinetic profile of 5-ketopyrazole factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(2). 749–754. 29 indexed citations
7.
Varnes, Jeffrey, Dean A. Wacker, Mimi L. Quan, et al.. (2007). Design, structure–activity relationship, and pharmacokinetic profile of pyrazole-based indoline factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(23). 6481–6488. 18 indexed citations
8.
Batt, Douglas G., John Roderick, Joseph B. Santella, et al.. (2004). N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 787–791. 12 indexed citations
9.
Varnes, Jeffrey, Daniel S. Gardner, Joseph B. Santella, et al.. (2004). Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists. Bioorganic & Medicinal Chemistry Letters. 14(7). 1645–1649. 21 indexed citations
10.
Xiao, Xiao, Rongshi Li, David C. Hurst, et al.. (2002). Solid-Phase Synthesis of Alkyl Aryl Ethers via the Ullmann Condensation. Journal of Combinatorial Chemistry. 4(5). 536–539. 7 indexed citations
11.
Wacker, Dean A., Joseph B. Santella, Daniel S. Gardner, et al.. (2002). CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 12(13). 1785–1789. 35 indexed citations
12.
Wacker, Dean A., et al.. (2002). Efficient solid-phase synthesis of 2,3-substituted indoles. Tetrahedron Letters. 43(29). 5189–5191. 40 indexed citations
13.
14.
15.
Wacker, Dean A., Frank Lovering, Richard J. Bridges, et al.. (1997). A Selective Photoaffinity Ligand for the Kainate Class of Excitatory Amino Acid Receptor. Synlett. 1997(Sup. I). 503–504. 2 indexed citations
16.
Nugiel, David A., Dean A. Wacker, & Gregory A. Nemeth. (1997). Facile preparation of chloromethylaryl solid supports using methanesulfonyl chloride and Hunig's base. Tetrahedron Letters. 38(33). 5789–5790. 13 indexed citations
17.
Bain, Jenny, Edward S. Diala, Charles Glabe, et al.. (1991). Site-specific incorporation of nonnatural residues during in vitro protein biosynthesis with semi-synthetic aminoacyl-tRNAs. Biochemistry. 30(22). 5411–5421. 89 indexed citations
18.
Bain, Jenny, et al.. (1991). Preparation of chemically misacylated semisynthetic nonsense suppressor tRNAs employed in biosynthetic incorporation of non-natural residues into proteins. The Journal of Organic Chemistry. 56(15). 4615–4625. 23 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie-Noëlle Dufour Breakdown of academic impact, for papers by Chongwu Zhang Breakdown of academic impact, for papers by V. V. Suresh Babu Breakdown of academic impact, for papers by Tadashi Tatsumi Breakdown of academic impact, for papers by Don O. Somers Breakdown of academic impact, for papers by Lars Linderoth Breakdown of academic impact, for papers by Jeffrey Varnes Breakdown of academic impact, for papers by Ronald Wolin Breakdown of academic impact, for papers by Mark Munson Breakdown of academic impact, for papers by J.‐R. DORMOY
Rankless by CCL
2026